4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-25-001047
Director acquired 779,900 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BARASCH RICHARD A Director | 2025-06-17 | Conversion | +159,500 | 1,935,141 | D | ||
| BARASCH RICHARD A Director | 2025-06-18 | Conversion | +620,400 | 2,555,541 | I | ||
| Derivatives | |||||||
| BARASCH RICHARD A Director | 2025-06-17 | Conversion · Class A Common Equivalent Preferred Stock | −1,595 | 0 | D | ||
| BARASCH RICHARD A Director | 2025-06-18 | Conversion · Class A Common Equivalent Preferred Stock | −6,204 | 0 | I | ||
Loading xslF345X05/ownership.xml…